CD274 and diabetes mellitus: The Idd3/10/18 strain develops diabetes with 31% incidence upon anti PDL1 treatment (days 4 to 28), which is ∼6-fold greater than the spontaneous incidence at the age of 7–8 months (Figure 1c, Table 1, 2).